A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing

Clinical trial NCT00381173 · COMPLETED

Trial details

NCT number: NCT00381173
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Ovarian Cancer Prostate Cancer Colon Cancer Renal Cancer

Start date: 2006-11-01
Primary completion: 2008-10-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.